Over the last 10 years, the evaluation of the neutrophil-to-lymphocyte ratio (NLR) as an emerging marker of diseases has become a compelling field of bio-medical research. Moreover, NLR was recently considered as part of the decision-making processes concerning the admission/recovery of patients with COVID-19 pneumonia.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Mar 26, 2022 |
| Journal | International Journal of Molecular Sciences |
| Authors | Agata Buonacera, Benedetta Stancanelli, Michele Colaci, Lorenzo Malatino |
| DOI | 10.3390/ijms23073636 |
| Citations | 958 |
| Source | OpenAlex |